克服抗菌素耐药性增加对Helicobacter pylori治疗的影响
David Yates Graham1, Theodore Rokkas2,3
1Department of Medicine, Michael E. DeBakey Veterans, Affairs Medical Center and Baylor College of Medicine, Houston, TX, USA.
Expert review of gastroenterology & hepatology
|December 11, 2024
概括
Helicobacter pylori (H. pylori) 的抗菌素耐药性是一个日益严重的全球性问题. 需要新的管理策略来对抗抗性的增加,并确保有效的H. pylori感染治疗.
科学领域:
- 微生物学 微生物学
- 传染性疾病 传染性疾病
- 药理学 药理学是指药理学的学科.
背景情况:
- 对Helicobacter pylori (H. pylori) 抗菌素耐药性的增加需要对当前的治疗策略进行重新评估.
- 以前对H. pylori有效的抗生素治疗方案在全球范围内变得越来越不成功.
研究的目的:
- 审查当前的管理方法,以应对抗菌素耐药性在H. pylori治疗.
- 要突出抗药性增加对H. pylori治疗疗效的影响.
主要方法:
- 文献综述侧重于抗菌素耐药性机制和H. pylori的管理策略.
- 对导致H. pylori耐药性的细菌和社会因素的分析.
- 讨论在H. pylori感染管理中的抗菌药物管理原则.
主要成果:
- H. pylori 抗菌素耐药性正在增加,需要纳入临床管理.
- 细菌因素 (突变,排泄,生物膜) 和社会因素 (过度使用/滥用抗生素) 驱动耐药性.
- 基于局部敏感性数据的优化治疗实践至关重要.
结论:
- 应使用抗微生物药物管理原则,将H. pylori感染作为传染病来管理.
- 建议传染病专家和胃肠病学家之间进行合作,以获得最佳的患者护理.
- 社区和医院的抗生素管理计划对于提供最新的治疗指导至关重要.
相关概念视频
Treating Helicobacter pylori in Peptic Ulcers: Antimicrobial Therapy
328
Helicobacter pylori, a resilient gram-negative bacterium, can thrive in the stomach's harsh, acidic environment. Infection with H. pylori leads to a cascade of events within the stomach lining. One of the critical disruptions caused by this bacterium is the interference with somatostatin production, a hormone responsible for regulating acid secretion. This interference tips the balance, escalating acid secretion and diminishing bicarbonate levels. This imbalance compromises the defensive...
328
Peptic Ulcer Disease IV: Management
72
Medical treatment strategies for peptic ulcers encompass various methods. The primary goal of treatment is to diminish gastric acidity and strengthen mucosal defense mechanisms.
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current...
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current...
72
Acid Suppressive Drugs for Peptic Ulcer Disease: Proton Pump Inhibitors
357
Peptic ulcers, often induced by H. pylori infections or NSAID usage, arise from disruptions in the delicate balance of gastric acid production. Peptic ulcers stem from heightened gastric acid levels due to H. pylori infections or NSAID use. The protective mucus layer diminishes in the presence of these factors, allowing gastric acid to erode the stomach lining and form ulcers.
Gastric acid, a potent cocktail of hydrogen and chloride ions, is produced in specialized parietal cells within the...
Gastric acid, a potent cocktail of hydrogen and chloride ions, is produced in specialized parietal cells within the...
357
Pathophysiology of Peptic Ulcer Disease: Mucosal Defense Factors
356
Peptic ulcer disease, commonly called PUD, represents a multifaceted condition characterized by disruptions in the lining of the gastrointestinal (GI) tract. Central to the protection of the gastrointestinal lining is the mucosal-bicarbonate barrier. This physiological defense mechanism is a formidable shield against the corrosive effects of gastric acid and pepsin secretion in the stomach. Its role is pivotal in maintaining the structural integrity of the stomach's inner lining.
356
Acid Suppressive Drugs for Peptic Ulcer Disease: Histamine H2-Receptor Antagonists
407
Histamine H2 receptors, which are intricately located on the basolateral membrane of parietal cells, play a crucial role in modulating gastric acid secretion. When released from enterochromaffin-like cells, histamine engages H2 receptors, initiating the cyclic AMP (cAMP) pathway. In this pathway, adenylyl cyclase converts ATP into cAMP, elevating intracellular cAMP levels. The activation of protein kinase A follows, stimulating the proton pump. This stimulation prompts the secretion of hydrogen...
407
Antibiotic Selection
52.3K
Overview
52.3K


